Filing Details

Accession Number:
0001209191-14-014626
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-26 20:03:14
Reporting Period:
2014-02-24
Filing Date:
2014-02-26
Accepted Time:
2014-02-26 20:03:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378166 David Young 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-24 14,000 $0.00 125,145 No 4 A Direct
Common Stock Acquisiton 2014-02-24 14,000 $0.00 139,145 No 4 A Direct
Common Stock Disposition 2014-02-24 16,667 $0.00 122,478 No 4 D Direct
Common Stock Disposition 2014-02-24 17,127 $79.46 105,351 No 4 F Direct
Common Stock Acquisiton 2014-02-24 6,000 $4.54 111,351 No 4 M Direct
Common Stock Disposition 2014-02-24 6,000 $78.88 105,351 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-02-24 6,000 $0.00 6,000 $4.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
83,000 2019-10-29 No 4 M Direct
Footnotes
  1. Restricted stock granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
  2. Represents a restricted stock award that vests in four equal annual installments beginning on 2/24/2015.
  3. Represents a restricted stock award that vests subject to the achievement of certain performance-based criteria.
  4. Represents the forfeiture of restricted stock granted on 2/24/2013 based on the level of achievement of performance criteria for fiscal year 2013.
  5. Represents the surrender of shares to the Company to satisfy the reporting person's aggregate tax withholding obligation upon the vesting of shares of restricted stock granted on 2/24/2013.
  6. Non-qualified stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on 10/30/2009.
  7. The option was granted on 10/30/2009 for the right to buy 350,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant with a twelve month cliff, whereby no options vested until after the twelfth month from the date of grant.